Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms SZU B6, SZUB6 |
Target |
Mechanism SIRT6 inhibitors(NAD-dependent protein deacetylase sirtuin-6 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatocellular Carcinoma | Preclinical | CN | 25 Sep 2024 |